Natriumvalproaat Chrono Teva (Valproic Acid, Sodium Valproate)

Valproic acid, the active ingredient in Natriumvalproaat Chrono Teva, is an anticonvulsant presented as an oral formulation for systemic use. It is employed to control seizures, stabilize mood in bipolar disorder, and prevent migraine attacks in adult patients.

GNH USA supplies Natriumvalproaat Chrono Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Natriumvalproaat Chrono Teva is an anticonvulsant medication used in several neurological and psychiatric conditions. - Epilepsy: reduces the frequency and severity of generalized and focal seizures. - Bipolar disorder: helps maintain mood stability and prevents manic episodes. - Migraine prophylaxis: decreases the number of migraine attacks when taken regularly.

Valproic acid may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea or abdominal discomfort - Weight gain or increased appetite - Tremor or fine motor instability - Dizziness or drowsiness - Hair thinning or loss - Gastro‑intestinal upset (diarrhoea, constipation)

Serious or Rare Side Effects: - Hepatic failure or severe liver injury - Acute pancreatitis - Life‑threatening skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis) - Thrombocytopenia or severe blood‑cell abnormalities - Hyperammonemic encephalopathy - Suicidal thoughts or behaviour

Before initiating therapy, clinicians should assess several safety parameters. - Pregnancy: Category D; avoid unless benefits outweigh risks. - Liver function: obtain baseline tests and monitor regularly. - Blood counts: monitor platelets and complete blood count periodically. - Drug interactions: review concomitant enzyme‑inducing agents. - Discontinuation: do not stop abruptly; taper under medical supervision. - Store at ambient temperature: keep in original packaging, protect from moisture and heat.

Valproic acid interacts with many medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid): - Carbamazepine, phenytoin, phenobarbital (reduce valproate levels) - Lamotrigine (risk of severe skin reactions) - Topiramate (increased risk of metabolic acidosis)

Moderate Interactions (Monitor Closely): - Oral contraceptives (reduced efficacy) - Warfarin (enhanced anticoagulant effect) - Antidepressants (serotonin syndrome risk) - Statins (potential for increased muscle toxicity) - Antiplatelet agents (heightened bleeding risk)